Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,132.40
(
0.00%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.66
(
-0.99%
)
Bitcoin
74,021.39
(
0.11%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 90128

Monday, 02/08/2010 4:24:31 AM

Monday, February 08, 2010 4:24:31 AM

Post# of 257253
Botox/Dysport info from AGN’s 4Q09 CC:

1. Dysport’s 4Q09 US market share: low double-digit % in cosmetic indications, and a negligible % in therapeutic indications (due to delays in Ipsen’s obtaining reimbursement).

2. Worldwide 4Q09 Botox sales were +0.7% year-over-year in local currencies (+5.6% in dollars).

3. Botox’s worldwide market share in all indications in 3Q09 (the most recent quarter for which data are available) is 83%.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now